Key Takeaways and Clinical Implications for Pharmacists

This program was supported by Jazz Pharmaceuticals, content independence maintained by Pharmacy Times.

In this final portion of the conversation, Matthew Arango, PharmD, reflects on the core principles pharmacists should keep front-of-mind when managing HER2-positive GEA. He shares perspectives on how the pharmacist’s role is poised to expand as new HER2-targeted therapies, biomarkers, and clinical data reshape the treatment landscape.